Department of Hematology/Oncology and Winship Cancer Institute, Emory University, Atlanta, Georgia 30322, USA.
Soc Work Health Care. 2011;50(10):815-27. doi: 10.1080/00981389.2011.595889.
There is lack of literature addressing factors that influence the process of care for patients with hematological malignancies. We evaluated the forms of social support available for patients with relapsed lymphoma considering stem cell transplantation and examined the influence of support on treatment delay. Data were collected from 119 patients with relapsed lymphoma using a questionnaire to capture sociodemographic information and emotional, informational, and instrumental forms of social support. Sixty-four percent of the patients were married, 56% had children over 18 years of age, 43% were employed, and 72% had private health insurance. Family members formed a major source of emotional support (83%), while 47% of patients considered personal prayers to be important. While 79% of patients received clinical support from nurses, few received formal group support or formal peer support (6.7% and 1.7% respectively). Support from extended family and peer groups reduced the likelihood of treatment delays. The potential benefits of peer group support should be reinforced for patients considering transplantation given how infrequent this form of social support is utilized and its positive impact on the process of care. Future studies should test the impact of social support on health outcomes especially among the underserved population.
目前缺乏针对影响血液系统恶性肿瘤患者治疗过程的因素的研究。我们评估了考虑干细胞移植的复发性淋巴瘤患者可获得的社会支持形式,并研究了支持对治疗延迟的影响。通过问卷调查收集了 119 例复发性淋巴瘤患者的数据,以获取社会人口统计学信息和情感、信息和工具形式的社会支持。64%的患者已婚,56%有 18 岁以上的子女,43%有工作,72%有私人医疗保险。家庭成员是情感支持的主要来源(83%),而 47%的患者认为个人祈祷很重要。尽管 79%的患者从护士那里获得了临床支持,但很少有患者获得正式的团体支持或正式的同伴支持(分别为 6.7%和 1.7%)。来自大家庭和同龄人群体的支持减少了治疗延迟的可能性。考虑到这种形式的社会支持利用频率较低,以及它对治疗过程的积极影响,应加强对正在考虑移植的患者提供同伴群体支持的潜在好处。未来的研究应检验社会支持对健康结果的影响,特别是在服务不足的人群中。